Page 184 - Vitamin D and Cancer
P. 184

7  Induction of Differentiation in Cancer Cells by Vitamin D    171

              137. Hewison M, Dabrowski M, Vadher S, Faulkner L, Cockerill FJ, Brickell PM, ÓRiordan JL,
               Katz DR (1996) Antisense inhibition of vitamin D receptor expression induces apoptosis in
               monoblastoid U937 cells. J Immunol 156:4391–4400
              138. Marcinkowska E, Chrobak A, Wiedlocha A (2001) Evading apoptosis by calcitriol-dif-
               ferentiated  human  leukemic  HL-60  cells  is  not  mediated  by  changes  in  CD95  receptor
               system but by increased sensitivity of these cells to insulin. Exp Cell Res 270:119–127
              139. Zhang Y, Zhang J, Studzinski GP (2006) AKT pathway is activated by 1, 25-dihydroxyvita-
               min D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating
               HL60 cells. Cell Cycle 5:447–451
             140.  Wang X, Studzinski GP (2006) The requirement for and changing composition of the activating
               protein-1 transcription factor during differentiation of human leukemia HL60 cells induced
               by 1, 25-dihydroxyvitamin D3. Cancer Res 66:4402–4409
              141. Nakagawa K, Kurobe M, Konno K, Fujishima T, Takayama H, Okano T (2000) Structure-
               specific control of differentiation and apoptosis of human promyelocytic leukemia (HL-60)
               cells  by  A-ring  diastereomers  of  2-methyl-1alpha,  25-dihydroxyvitamin  D3  and  its
               20-epimer. Biochem Pharmacol 60:1937–1947
              142. Urahama N, Ito M, Sada A, Yakushijin K, Yamamoto K, Okamura A, Minagawa K, Hato A,
               Chihara K, Roeder RG, Matsui T (2005) The role of transcriptional coactivator TRAP220 in
               myelomonocytic differentiation. Genes Cells 10:1127–1137
              143. Ikezoe T, Bandobashi K, Yang Y, Takeuchi S, Sekiguchi N, Sakai S, Koeffler HP, Taguchi H
               (2006) HIV-1 protease inhibitor ritonavir potentiates the effect of 1, 25-dihydroxyvitamin D3
               to  induce  growth  arrest  and  differentiation  of  human  myeloid  leukemia  cells  via  down-
               regulation of CYP24. Leuk Res 30:1005–1011
              144. Takahashi E, Nakagawa K, Suhara Y, Kittaka A, Nihei K, Konno K, Takayama H, Ozono K,
               Okano T (2006) Biological activities of 2alpha-substituted analogues of 1alpha, 25-dihy-
               droxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60)
               cell proliferation and differentiation. Biol Pharm Bull 29:2246–2250
              145. Suzuki T, Tazoe H, Taguchi K, Koyama Y, Ichikawa H, Hayakawa S, Munakata H, Isemura
               M (2006) DNA microarray analysis of changes in gene expression induced by 1, 25-dihy-
               droxyvitamin D3 in human promyelocytic leukemia HL-60 cells. Biomed Res 27:99–109
              146. Hughes PJ, Brown G (2006) 1Alpha, 25-dihydroxyvitamin D3-mediated stimulation of ste-
               roid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activa-
               tion of the RAS/RAF/ERK-MAP kinase signalling pathway. J Cell Biochem 98:590–617
              147. Hughes PJ, Lee JS, Reiner NE, Brown G (2008) The vitamin D receptor-mediated activation
               of phosphatidylinositol 3-kinase (PI3Kalpha) plays a role in the 1alpha, 25-dihydroxyvitamin
               D3-stimulated increase in steroid sulphatase activity in myeloid leukaemic cell lines. J Cell
               Biochem 103:1551–1572
              148. Munker  R,  Kobayashi  T,  Elstner  E,  Norman  AW,  Uskokovic  M,  Zhang  W,  Andreeff  M,
               Koeffler HP (1996) A new series of vitamin D analogs is highly active for clonal inhibition,
               differentiation, and induction of WAF1 in myeloid leukemia. Blood 88:2201–2209
              149. Muto  A,  Kizaki  M,  Yamato  K,  Kawai  Y,  Kamata-Matsushita  M,  Ueno  H,  Ohguchi  M,
               Nishihara T, Koeffler HP, Ikeda Y (1999) 1, 25-Dihydroxyvitamin D3 induces differentiation
               of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with
               expression of p21(WAF1/CIP1) and p27(KIP1). Blood 93:2225–2233
              150. Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP
               (2001) 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent anti-
               leukemic effects from their lack of calcium modulation. Cancer Res 61:3361–3368
              151. ÓKelly J, Uskokovic M, Lemp N, Vadgama J, Koeffler HP (2006) Novel Gemini-vitamin D3
               analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway. J Steroid
               Biochem Mol Biol 100:107–16
              152. Wang X, Studzinski GP (2001) Activation of extracellular signal-regulated kinases (ERKs)
               defines the first phase of 1, 25-dihydroxyvitamin D3-induced differentiation of HL60 cells.
               J Cell Biochem 80:471–482
   179   180   181   182   183   184   185   186   187   188   189